These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22738692)
1. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris. Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up. Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070 [TBL] [Abstract][Full Text] [Related]
3. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis. Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A; Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627 [TBL] [Abstract][Full Text] [Related]
4. Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents. Tandjung K; Basalus MW; Muurman E; Louwerenburg HW; van Houwelingen KG; Stoel MG; de Man FH; Jansen H; Huisman J; Linssen GC; Droste HT; Nienhuis MB; von Birgelen C Catheter Cardiovasc Interv; 2012 Oct; 80(4):524-30. PubMed ID: 22109857 [TBL] [Abstract][Full Text] [Related]
5. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry. Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512 [TBL] [Abstract][Full Text] [Related]
7. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW; Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019 [TBL] [Abstract][Full Text] [Related]
8. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW; Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227 [TBL] [Abstract][Full Text] [Related]
9. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897 [TBL] [Abstract][Full Text] [Related]
10. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
11. Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients. Her AY; Kim YH; Garg S; Shin ES Coron Artery Dis; 2018 Aug; 29(5):403-408. PubMed ID: 29620557 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778 [TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]
15. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088 [TBL] [Abstract][Full Text] [Related]
16. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
17. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Ali ZA; Roleder T; Narula J; Mohanty BD; Baber U; Kovacic JC; Mintz GS; Otsuka F; Pan S; Virmani R; Sharma SK; Moreno P; Kini AS Circ Cardiovasc Interv; 2013 Oct; 6(5):507-17. PubMed ID: 24065447 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G; EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062 [TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634 [TBL] [Abstract][Full Text] [Related]
20. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]